SCHEMBL7136169

SCHEMBL7136169

CCOC(=O)c1[nH]c(C=C2C(=O)Nc3c(Br)cc(Br)c(C)c32)c(C(=O)OC)c1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
POLB P06746 1/20 0.44
KMT2A Q03164 1/20 0.44
ABL1 P00519 1/20 0.39
RET P07949 1/20 0.39
PDGFRB P09619 1/20 0.39
FGFR1 P11362 1/20 0.39
FLT3 P36888 1/20 0.39
ALK Q9UM73 1/20 0.39
HPGD P15428 2/20 0.37
KDR P35968 1/20 0.37
RAB9A P51151 4/20 0.36
NPC1 O15118 3/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
TSHR P16473 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
MAPT P10636 1/20 0.35
LMNA P02545 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5358202 0.85 PDGFRB (0.45) ALDH1A1POLBKMT2AABL1RET
SCHEMBL7136788 0.82 PDGFRB (0.58) ALDH1A1POLBKMT2AABL1RET
SCHEMBL5362213 0.79 MEN1 (0.33) ALDH1A1KMT2APDGFRBFGFR1KDR
SCHEMBL7131038 0.78 NPSR1 (0.34) ALDH1A1POLBKMT2ARAB9ANPC1
SCHEMBL5358435 0.74 KDR (0.53) ALDH1A1POLBKMT2AABL1RET
SCHEMBL7137028 0.73 MAOB (0.38) ALDH1A1POLBKMT2AABL1RET
SCHEMBL5991909 0.73 ABL1 (0.45) ALDH1A1POLBKMT2AABL1RET
SCHEMBL5989093 0.73 ALDH1A1 (0.42) ALDH1A1POLBKMT2AABL1RET
SCHEMBL5988621 0.72 KDR (0.52) ALDH1A1POLBKMT2AABL1RET
SCHEMBL5990240 0.72 PDGFRB (0.51) ALDH1A1POLBKMT2AABL1RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506763-B2 Useful in prevention and treatment of protein kinase related disorders such as cancer SUGEN, INC. 2003-01-14 US disclosed